These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9875243)

  • 1. The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer.
    Kantoff P; Giovannucci E; Brown M
    Biochim Biophys Acta; 1998 Nov; 1378(3):C1-5. PubMed ID: 9875243
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
    Santos ML; Sarkis AS; Nishimoto IN; Nagai MA
    Cancer Detect Prev; 2003; 27(5):321-6. PubMed ID: 14585317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
    Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
    Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The androgen receptor CAG repeat and prostate cancer risk.
    Clark PE; Irvine RA; Coetzee GA
    Methods Mol Med; 2003; 81():255-66. PubMed ID: 12725125
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer.
    Klotz L; Correia A; Zhang W
    Prostate Cancer Prostatic Dis; 2005; 8(2):179-83. PubMed ID: 15809670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a short CAG (glutamine) repeat on human androgen receptor function.
    Ding D; Xu L; Menon M; Reddy GP; Barrack ER
    Prostate; 2004 Jan; 58(1):23-32. PubMed ID: 14673949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.
    Giovannucci E; Stampfer MJ; Krithivas K; Brown M; Dahl D; Brufsky A; Talcott J; Hennekens CH; Kantoff PW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3320-3. PubMed ID: 9096391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
    Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
    Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
    Andersson P; Varenhorst E; Söderkvist P
    Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size of the androgen receptor CAG repeat and prostate cancer: does it matter?
    Coetzee G; Irvine R
    J Clin Oncol; 2002 Sep; 20(17):3572-3. PubMed ID: 12202654
    [No Abstract]   [Full Text] [Related]  

  • 15. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor CAG repeats and prostate cancer.
    Nelson KA; Witte JS
    Am J Epidemiol; 2002 May; 155(10):883-90. PubMed ID: 11994226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the androgen receptor CAG repeat length significant for prostate cancer?
    Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):985-6. PubMed ID: 12376496
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.